SUTRO BIOPHARMA, INC. current report, 28 February 2022

Full document

Sutro Biopharma, Inc. (STRO) - Form 8-K Summary

Business Context and Reporting Period

Sutro Biopharma, Inc., a Delaware corporation, filed this Current Report on Form 8-K on February 28, 2022. The filing serves to announce the company's financial results for the fiscal year ended December 31, 2021. The company's common stock trades on The Nasdaq Global Market under the symbol STRO.

Key Financial Metrics

This Form 8-K is a notification of results and does not contain specific financial data points within its text. The filing references a press release (Exhibit 99.1) for detailed figures. Consequently, the following metrics are not provided in this document:

  • Revenue: Not stated in filing text.
  • Profit/Loss: Not stated in filing text.
  • Cash Flow: Not stated in filing text.
  • Margins: Not stated in filing text.
  • Debt and Liquidity: Not stated in filing text.

Material Changes

The filing does not detail specific material changes or comparative financial data versus the prior period. It solely indicates that results for the year ended December 31, 2021, have been issued.

Guidance, Outlook, and Risks

The text of this 8-K does not contain management commentary, forward-looking guidance, specific risk factors, or details on contingencies. It explicitly states that the information furnished, including the attached press release, is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings except as expressly set forth.

Investor Verification Checklist

  • Review Exhibit 99.1 (the attached press release) for the actual numerical financial results for the year ended December 31, 2021.
  • Verify the company's cash position and burn rate in the full press release, as this 8-K contains no liquidity data.
  • Check for any updated clinical trial milestones or pipeline progress mentioned in the press release, as this 8-K only announces the release of results.
  • Confirm the status of the company's debt obligations and working capital in the detailed financial statements referenced by the press release.